Enforcement, Litigation, and Compliance Conference: For the Drug, Device, Food, and Tobacco Industries

Overview

Register

Super early registration expires 7/31/2025

Call for Proposals—BE CREATIVE! 

FDLI invites you to submit a topic proposal for a session at the Enforcement, Litigation, and Compliance Conference. Your submissions and input are integral to ensuring that the most timely and pertinent topics are covered at the conference. Topics should address timely and important issues relating to enforcement, compliance, or litigation issues as it affects the FDA-regulated community. Topics can be related to a specific FDA-regulated product (e.g.,  drugs, biologics, medical devices, tobacco and nicotine products, cosmetics, veterinary medicines, cannabis products, or food and dietary supplements) or be relevant to all. Thank you in advance for your submission! 

Proposal Submission Guidelines 

• Topics should be at an advanced level. 

• Topics that include a variety of perspectives and viewpoints, including government, industry, private attorneys, academics, and public interest are preferred. 

• FDLI is committed to supporting, promoting, and celebrating diversity and inclusion in the food and drug law community. To that end, proposals addressing systematic or historical impacts on health care disparity and racial equity in relation to all areas of the FDA-regulated community are strongly encouraged. 

• We prefer submissions to include a reasonably detailed and thoughtful title for and description of the proposed session.  

Submissions FAQ 

• Q: Am I limited in the number of proposals I can submit? 

• A: Multiple submissions from the same person or organization are welcome—however, each proposal requires its own form.  

• Q: How will my submission be reviewed? 

• A: All submissions are blinded before being reviewed by the Conference Planning Committee. All submissions are treated as recommendations, and proposals may be modified or combined by FDLI to best suit the needs of the conference.  

• Q: Do all items in my proposal need to be in final form?  

• A: No—Your proposal does not need to be in final form. A proposal can and will likely be updated by the Committee to include the newest or most up-to-date information as relevant for the FDLI audience. 

• Should I reach out to speakers I suggest in advance of submitting my proposal? 

• A: Suggested speakers should not be invited in advance—sessions are often combined and we cannot guarantee that suggested speakers will be included. 

• Q: Can I email you my submission? 

• All submissions must be received through the submission portal. 

• Q: If my topic is selected, do I get to speak? Do I have to speak if my topic is selected? 

• A: Speaking opportunities are generally reserved for FDLI members. If your topic is selected, you will be invited to speak if you are interested; however, speaking is not a requirement to submit a topic.  

• Q: How will I know if my submission is accepted? 

• A: You will be notified of the status of your submission approximately three months before the conference date. 

Proposal Submission Timeline 

• May 23, 2025: Call for Proposals closes. 

• August 2025: Those who submitted proposals will be notified of their submission’s status. 

Sponsors

Sponsorship opportunities are available. Contact Cathy Scolieri for more information.
View 2025 Sponsorship Opportunities

 

Planning Committee

Committee Members

Cathy L. Burgess , Alston & Bird LLP
John Claud, Hyman, Phelps & McNamara, PC
Jason Drori, Vertex Pharmaceuticals, Inc.
Lynne Ensor, NSF International
Maya P. Florence, Skadden, Arps, Slate, Meagher & Flom LLP
Teresa Gorecki, Compliance Architects LLC
Monica Groat, Latham & Watkins LLP
Dennis C. Gucciardo, Morgan, Lewis & Bockius LLP
Steven A. Johnson, FDACOUNSELS.COM
Mark Carlisle Levy, Eckert Seamans Cherin & Mellott, LLC
Clint Narver, McGuireWoods LLP
Bob Rhoades, ELIQUENT Life Sciences
Lee Rosebush, BakerHostetler
Colin Stabler, Exponent, Inc.
Xin Tao, Baker McKenzie
Eva A. Temkin, Arnold & Porter LLP
Jessica Tierney, Jones Day
George Toscano, Toscano Consulting Group (TCG)
Christopher Van Gundy, Sheppard Mullin Richter & Hampton LLP
Jack Wenik, Epstein Becker & Green, PC